Daniel C. Martin - 16 Jan 2024 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc.

Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Jan 2024
Net transactions value
-$23,499
Form type
4
Filing time
18 Jan 2024, 16:15:19 UTC
Previous filing
14 Dec 2023
Next filing
20 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale $23,499 -1,624 -3.3% $14.47 47,660 16 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock units.